chr3-7209746-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000844.4(GRM7):​c.736+63078A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.281 in 152,158 control chromosomes in the GnomAD database, including 6,125 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 6125 hom., cov: 33)

Consequence

GRM7
NM_000844.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.08

Publications

5 publications found
Variant links:
Genes affected
GRM7 (HGNC:4599): (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
GRM7 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.298 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000844.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
NM_000844.4
MANE Select
c.736+63078A>G
intron
N/ANP_000835.1
GRM7
NM_181874.3
c.736+63078A>G
intron
N/ANP_870989.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
ENST00000357716.9
TSL:1 MANE Select
c.736+63078A>G
intron
N/AENSP00000350348.4
GRM7
ENST00000389336.8
TSL:1
c.736+63078A>G
intron
N/AENSP00000373987.4
GRM7
ENST00000389335.7
TSL:1
n.736+63078A>G
intron
N/AENSP00000373986.3

Frequencies

GnomAD3 genomes
AF:
0.282
AC:
42802
AN:
152040
Hom.:
6129
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.283
Gnomad AMI
AF:
0.258
Gnomad AMR
AF:
0.232
Gnomad ASJ
AF:
0.363
Gnomad EAS
AF:
0.126
Gnomad SAS
AF:
0.252
Gnomad FIN
AF:
0.274
Gnomad MID
AF:
0.392
Gnomad NFE
AF:
0.302
Gnomad OTH
AF:
0.305
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.281
AC:
42802
AN:
152158
Hom.:
6125
Cov.:
33
AF XY:
0.281
AC XY:
20883
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.282
AC:
11728
AN:
41526
American (AMR)
AF:
0.231
AC:
3537
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.363
AC:
1259
AN:
3468
East Asian (EAS)
AF:
0.126
AC:
651
AN:
5168
South Asian (SAS)
AF:
0.252
AC:
1213
AN:
4820
European-Finnish (FIN)
AF:
0.274
AC:
2905
AN:
10590
Middle Eastern (MID)
AF:
0.364
AC:
107
AN:
294
European-Non Finnish (NFE)
AF:
0.302
AC:
20521
AN:
67988
Other (OTH)
AF:
0.306
AC:
646
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1603
3205
4808
6410
8013
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.295
Hom.:
3861
Bravo
AF:
0.278
Asia WGS
AF:
0.178
AC:
620
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.091
DANN
Benign
0.35
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6769814; hg19: chr3-7251433; API